EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline

Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Iran cảnh báo đáp trả nếu Mỹ cân nhắc phương án quân sự

Iran cảnh báo đáp trả nếu Mỹ cân nhắc phương án quân sự

Thế giới
(Baothanhhoa.vn) - Ngày 11/1, Iran cảnh báo các lực lượng quân sự của Mỹ và Israel sẽ bị coi là “mục tiêu hợp pháp” trong trường hợp nước này hứng chịu một cuộc tấn công, trong bối cảnh Tổng thống Mỹ Donald Trump được cho là đang xem xét các phương án quân sự liên...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh